We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
+18.1%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
–
AUM
$1.52B
AUM Growth
+$95.3M
Cap. Flow
-$53M
Cap. Flow %
-3.48%
Top 10 Hldgs %
46.4%
Holding
811
New
169
Increased
201
Reduced
172
Closed
223

Top Buys

Rank Stock Value
1
PTCT icon
PTC Therapeutics
PTCT
+$66.9M
2
SAGE
Sage Therapeutics
SAGE
+$26.6M
3
IMO icon
Imperial Oil
IMO
+$24.9M
4
COIN icon
Coinbase
COIN
+$22.5M
5
ANSCU
Agriculture & Natural Solutions Acquisition Corp Unit
ANSCU
+$21.6M

Top Sells

Rank Stock Value
1
MSOS icon
AdvisorShares Pure US Cannabis ETF
MSOS
+$48.7M
2
AAC
Ares Acquisition Corporation
AAC
+$36.4M
3
PTGX icon
Protagonist Therapeutics
PTGX
+$27.6M
4
HCVIU
Hennessy Capital Investment Corp. VI Unit
HCVIU
+$17.4M
5
NETD
Nabors Energy Transition Corp II
NETD
+$16.9M

Sector Composition

Rank Sector Weight
1 Healthcare 30.8%
2 Financials 24.54%
3 Technology 21.73%
4 Communication Services 4.41%
5 Energy 3.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KRTX
76
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$3.48M 0.23%
+10,999
New +$2.14M
TSVT
77
DELISTED
2seventy bio
TSVT
$3.42M 0.22%
+800,000
New +$2.46M
MCAA
78
DELISTED
Mountain & Co. I Acquisition Corp. Class A Ordinary Shares
MCAA
$3.38M 0.22%
298,699
-188,471
-39% -$2.11M
BHVN icon
79
Biohaven
BHVN
$2.19B
$3.35M 0.22%
+78,319
New +$2.44M
OPA
80
DELISTED
Magnum Opus Acquisition Limited
OPA
$3.23M 0.21%
+299,721
New +$3.21M
IRRX
81
DELISTED
Integrated Rail and Resources Acquisition Corp.
IRRX
$3.22M 0.21%
+292,642
New +$3.2M
KCGI
82
DELISTED
Kensington Capital Acquisition Corp. V
KCGI
$3.21M 0.21%
300,100
+30,335
+11% +$322K
TCOA
83
DELISTED
Zalatoris Acquisition Corp.
TCOA
$3.2M 0.21%
300,348
-31,660
-10% -$336K
CEF icon
84
Sprott Physical Gold and Silver Trust
CEF
$8.3B
$3.14M 0.21%
164,132
-200,000
-55% -$3.69M
GLAC
85
DELISTED
Global Lights Acquisition Corp Ordinary Shares
GLAC
$3.03M 0.2%
+300,550
New +$3.03M
BAYA
86
DELISTED
Bayview Acquisition Corp
BAYA
$2.98M 0.2%
+297,946
New +$2.98M
CMCA
87
DELISTED
Capitalworks Emerging Markets Acquisition Corp Class A Ordinary Shares
CMCA
$2.95M 0.19%
271,370
+33,716
+14% +$365K
EVE
88
DELISTED
EVe Mobility Acquisition Corp
EVE
$2.94M 0.19%
271,901
-174,044
-39% -$1.87M
IMVT icon
89
Immunovant
IMVT
$8.24B
$2.92M 0.19%
+69,410
New +$2.55M
BBIO icon
90
BridgeBio Pharma
BBIO
$16.6B
$2.91M 0.19%
+72,141
New +$2.17M
BREZ
91
DELISTED
Breeze Holdings Acquisition Corp. Common Stock
BREZ
$2.76M 0.18%
250,000
– –
PLMJ
92
DELISTED
Plum Acquisition Corp. III Class A Ordinary Shares
PLMJ
$2.76M 0.18%
257,803
+194,742
+309% +$2.07M
AILE
93
DELISTED
iLearningEngines, Inc. Common Stock
AILE
$2.67M 0.18%
255,180
– –
IONS icon
94
Ionis Pharmaceuticals
IONS
$9.46B
$2.6M 0.17%
+51,415
New +$2.46M
RENE
95
DELISTED
Cartesian Growth Corp II
RENE
$2.47M 0.16%
225,626
-336,900
-60% -$3.67M
NBIX icon
96
Neurocrine Biosciences
NBIX
$16.8B
$2.46M 0.16%
+18,668
New +$2.15M
PCVX icon
97
Vaxcyte
PCVX
$8.67B
$2.39M 0.16%
+38,092
New +$1.98M
LIBY
98
DELISTED
Liberty Resources Acquisition Corp. Class A Common Stock
LIBY
$2.37M 0.16%
+216,292
New +$2.36M
TEX icon
99
Terex
TEX
$7.58B
$2.31M 0.15%
+40,202
New +$2.08M
IRWD icon
100
Ironwood Pharmaceuticals
IRWD
$669M
$2.29M 0.15%
+200,578
New +$1.98M
2 3
4
5 6

Similar funds

CIP
Chartwell Investment Partners Berywn, Pennsylvania $2.91B AUM 40.48% 1-Year Est. Return
PWLP
Prio Wealth Limited Partnership Boston, Massachusetts $3.41B AUM 44.09% 1-Year Est. Return
FPCG
Fort Pitt Capital Group Pittsburgh, Pennsylvania $3.55B AUM 34.86% 1-Year Est. Return
SI
Scout Investments Kansas City, Missouri $3.8B AUM 45.91% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
FTDI
First Trust Direct Indexing Boston, Massachusetts $1.87B AUM 43.63% 1-Year Est. Return
CIM
Contrarius Investment Management St. Helier, Jersey $1.76B AUM 35.87% 1-Year Est. Return
PRO
Pensioenfonds Rail & OV Utrecht, Netherlands $1.44B AUM 23.73% 1-Year Est. Return

Cowen and Company's Q4 2023 Portfolio in Review

As of Q4 2023, Cowen and Company held 811 positions worth $1.52B, up 6.7% from $1.43B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Cowen and Company withdrew a net $53M in Q4 2023, closing 223 positions and reducing 172 holdings. Its most notable exit was AdvisorShares Pure US Cannabis ETF, an estimated $48.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 22% a quarter earlier, followed by Financials and Technology.

Against the trend, Cowen and Company opened a new position in Sage Therapeutics worth $29M.

  • Cowen and Company's largest Q4 2023 buy was Sage Therapeutics: 1,339,971 shares worth $29M.
  • Cowen and Company added most to PTC Therapeutics in Q4 2023, an estimated $66.9M increase.
  • Cowen and Company's biggest Q4 2023 reduction was Nabors Energy Transition Corp II, cutting an estimated $16.9M.
  • Cowen and Company fully exited AdvisorShares Pure US Cannabis ETF in Q4 2023, selling an estimated $48.7M.
  • Cowen and Company's ten largest holdings make up 46% of its $1.52B portfolio in Q4 2023.
  • Cowen and Company opened 169 new positions and closed 223 in Q4 2023.
  • Cowen and Company's portfolio value rose 6.7% quarter-over-quarter to $1.52B.

Based on Cowen and Company's 13F filing for Q4 2023, filed 8 Feb 2024.